Eur Rev Med Pharmacol Sci 2025; 29 (7): 348-348
DOI: 10.26355/eurrev_202507_37339

Expression of Concern

No Authors listed

Not available


The Editor in Chief and the Publisher are issuing an expression of concern regarding the following article:

Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte and embryo quality in PCOS patients having a normal insulin response. Eur Rev Med Pharmacol Sci. 2011 Apr; 15(4): 452-457. PMID: 21608442.

This Expression of Concern is issued following a notification from a third party concerning a potential conflict of interest involving Dr. Unfer’s role at Loli Pharma, the company marketing inositol-based products.

This expression of concern aims to notify a possible bias arising from an undeclared conflict of interest.

The authors have been notified of both the ongoing investigation and the publication of this notice.

Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial

Free PDF Download

To cite this article

No Authors listed
Expression of Concern

Eur Rev Med Pharmacol Sci
Year: 2025
Vol. 29 - N. 7
Pages: 348-348
DOI: 10.26355/eurrev_202507_37339

Publication History

Published online: 31 Jul 2025